Lsv Asset Management Ironwood Pharmaceuticals Inc Transaction History

Lsv Asset Management

$43.3 Billion
Q4 2024

A detailed history of Lsv Asset Management transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Lsv Asset Management holds 4,081,501 shares of IRWD stock, worth $6.98 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,081,501

Previous 5,051,601 19.2%

Holding current value

$6.98 Million

Previous $20.8 Million 13.13%

% of portfolio

0.04%

Previous 0.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$3.34 - $5.04 $3.24 Million - $4.89 Million	-970,100 Reduced 19.2%	4,081,501 $18.1 Million
Q3 2024 Nov 12, 2024	SELL	$3.93 - $7.04 $4.01 Million - $7.18 Million	-1,019,900 Reduced 16.8%	5,051,601 $20.8 Million
Q2 2024 Aug 06, 2024	SELL	$5.58 - $8.61 $443,610 - $684,495	-79,500 Reduced 1.29%	6,071,501 $39.6 Million
Q1 2024 May 06, 2024	SELL	$8.32 - $15.45 $5.25 Million - $9.75 Million	-631,100 Reduced 9.31%	6,151,001 $53.6 Million
Q4 2023 Feb 06, 2024	SELL	$8.79 - $11.51 $3.36 Million - $4.4 Million	-382,108 Reduced 5.33%	6,782,101 $77.6 Million
Q3 2023 Nov 03, 2023	SELL	$8.25 - $11.35 $4.18 Million - $5.74 Million	-506,100 Reduced 6.6%	7,164,209 $69 Million
Q2 2023 Aug 02, 2023	BUY	$10.1 - $11.6 $935,260 - $1.07 Million	92,600 Added 1.22%	7,670,309 $81.6 Million
Q1 2023 May 02, 2023	SELL	$10.37 - $12.56 $3.62 Million - $4.38 Million	-348,688 Reduced 4.4%	7,577,709 $79.7 Million
Q4 2022 Feb 08, 2023	BUY	$9.9 - $12.43 $120,552 - $151,360	12,177 Added 0.15%	7,926,397 $98.2 Million
Q3 2022 Nov 07, 2022	BUY	$10.14 - $12.38 $4.41 Million - $5.39 Million	435,063 Added 5.82%	7,914,220 $82 Million
Q2 2022 Aug 10, 2022	BUY	$11.05 - $12.72 $793,688 - $913,639	71,827 Added 0.97%	7,479,157 $86.2 Million
Q1 2022 May 12, 2022	SELL	$10.61 - $12.88 $1.06 Million - $1.29 Million	-100,076 Reduced 1.33%	7,407,330 $93.2 Million
Q4 2021 Jan 28, 2022	SELL	$10.86 - $13.95 $3.31 Million - $4.25 Million	-304,821 Reduced 3.9%	7,507,406 $87.5 Million
Q3 2021 Nov 04, 2021	BUY	$11.92 - $13.92 $41.1 Million - $48 Million	3,448,000 Added 79.01%	7,812,227 $102 Million
Q2 2021 Aug 04, 2021	BUY	$10.16 - $13.11 $34.4 Million - $44.4 Million	3,390,228 Added 348.07%	4,364,227 $56.2 Million
Q1 2021 Apr 30, 2021	BUY	$9.04 - $11.86 $8.8 Million - $11.6 Million	973,999 New	973,999 $10.9 Million

Others Institutions Holding IRWD

# of Institutions

243

Shares Held

163M

Call Options Held

11.5M

Put Options Held

12.9K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $262M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Account

Lsv Asset Management Ironwood Pharmaceuticals Inc Transaction History